Themis Medicare Share Price

209.10-0.69 (-0.33%)
Volume: 47,970

Live
Last Updated On: 02 Jul, 2024, 02:48 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Themis Medicare Share P...

209.10-0.69 (-0.33%)
Volume: 47,970

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About
More
- MF
- F&O
- Corp Actions
- About
EnglishEnglishहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ தமிழ்తెలుగు

Themis Medicare share price insights

View All

Employee & Interest Expense
Company has spent 2.46% of its operating revenues towards interest expenses and 21.59% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 177.91% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Decrease in Cash from Investing
Company has used Rs 15.95 cr for investing activities which is an YoY decrease of 33.44%. (Source: Consolidated Financials)
Stock Returns vs Nifty Pharma
Stock generated 177.91% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Themis Medicare Share Price Update
Themis Medicare Ltd. share price moved down by -0.33% from its previous close of Rs 209.78. Themis Medicare Ltd. stock last traded price is 209.10
Share Price Value
Today/Current/Last 209.10208.40
Previous Day 209.78209.55

Share Price	Value
Today/Current/Last	209.10208.40
Previous Day	209.78209.55

InsightsThemis Medicare

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

44.32

EPS - TTM

(₹)

4.73

MCap

(₹ Cr.)

1,923.73

Sectoral MCap Rank

PB Ratio

(x)

5.11

Div Yield

(%)

0.24

Face Value

(₹)

1.00

Beta

1.23

VWAP

(₹)

211.40

52W H/L

(₹)

263.85 / 132.60

Themis Medicare Share Price Returns

1 Day	-0.33%
1 Week	-4.63%
1 Month	3.13%
3 Months	-7.21%
1 Year	53.8%
3 Years	212.42%
5 Years	891.7%

ET Stock ScreenersTop Score Companies

Check whether Themis Medicare belongs to analysts' top-rated companies list?

View Stock Screeners

Themis Medicare News & Analysis

View all Themis Medicare Share News & Announcements

Themis Medicare Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Themis Medicare Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Themis Medicare Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Employee & Interest Expense
Company has spent 2.46% of its operating revenues towards interest expenses and 21.59% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	98.92	83.08	107.22	97.30	83.05
Total Income Growth (%)	19.07	-22.52	10.19	17.16	-12.28
Total Expenses	91.58	77.55	95.45	77.93	72.42
Total Expenses Growth (%)	18.09	-18.76	22.48	7.61	-4.94
EBIT	7.34	5.53	11.77	19.37	10.63
EBIT Growth (%)	32.69	-53.01	-39.22	82.19	-42.51
Profit after Tax (PAT)	6.64	7.37	11.32	18.19	8.41
PAT Growth (%)	-9.83	-34.91	-37.78	116.44	-36.86
EBIT Margin (%)	7.42	6.66	10.98	19.91	12.80
Net Profit Margin (%)	6.72	8.87	10.56	18.70	10.12
Basic EPS (₹)	0.72	0.80	12.30	19.77	9.13

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	98.92	83.08	107.22	97.30	83.05
Total Income Growth (%)	19.07	-22.52	10.19	17.16	-12.28
Total Expenses	91.56	77.54	95.45	77.93	72.41
Total Expenses Growth (%)	18.08	-18.76	22.48	7.62	-4.94
EBIT	7.36	5.54	11.77	19.37	10.64
EBIT Growth (%)	32.90	-52.98	-39.22	82.11	-42.49
Profit after Tax (PAT)	3.09	2.00	7.10	12.56	6.04
PAT Growth (%)	54.45	-71.80	-43.46	107.76	-50.00
EBIT Margin (%)	7.44	6.66	10.98	19.91	12.81
Net Profit Margin (%)	3.13	2.41	6.62	12.90	7.28
Basic EPS (₹)	0.34	0.22	7.71	13.64	6.57

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	386.52	365.83	401.16	234.29	205.05
Total Revenue Growth (%)	5.66	-8.81	71.22	14.26	9.99
Total Expenses	351.88	306.93	317.23	202.44	187.08
Total Expenses Growth (%)	14.64	-3.25	56.71	8.21	-7.06
Profit after Tax (PAT)	43.52	56.90	72.88	35.70	24.78
PAT Growth (%)	-23.51	-21.93	104.13	44.07	-
Operating Profit Margin (%)	11.52	19.32	23.49	19.32	15.30
Net Profit Margin (%)	11.40	16.05	18.46	15.47	12.29
Basic EPS (₹)	4.73	61.83	79.22	38.86	26.97

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	386.52	365.83	401.16	234.29	205.06
Total Revenue Growth (%)	5.66	-8.81	71.22	14.26	9.77
Total Expenses	351.85	306.92	317.22	202.04	187.05
Total Expenses Growth (%)	14.64	-3.25	57.00	8.01	-7.09
Profit after Tax (PAT)	24.75	43.29	61.56	26.62	15.91
PAT Growth (%)	-42.84	-29.67	131.24	67.30	-
Operating Profit Margin (%)	11.53	19.32	23.49	19.49	15.32
Net Profit Margin (%)	6.48	12.21	15.59	11.54	7.89
Basic EPS (₹)	2.69	47.05	66.91	28.97	17.32

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	566.42	513.96	427.78	371.14	349.91
Total Assets Growth (%)	10.21	20.14	15.26	6.07	11.40
Total Liabilities	188.75	174.51	140.29	152.63	166.89
Total Liabilities Growth (%)	8.16	24.39	-8.09	-8.54	6.96
Total Equity	377.67	339.44	287.49	218.51	183.02
Total Equity Growth (%)	11.26	18.07	31.57	19.39	15.78
Current Ratio (x)	1.90	1.90	1.96	1.45	1.17
Total Debt to Equity (x)	0.25	0.27	0.27	0.36	0.48
Contingent Liabilities	18.76	18.75	13.75	16.56	12.77

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	489.97	456.29	383.74	338.40	326.18
Total Assets Growth (%)	7.38	18.91	13.40	3.75	8.97
Total Liabilities	188.69	174.46	140.26	152.60	166.87
Total Liabilities Growth (%)	8.16	24.38	-8.09	-8.55	6.97
Total Equity	301.28	281.83	243.48	185.80	159.31
Total Equity Growth (%)	6.90	15.75	31.04	16.63	11.14
Current Ratio (x)	1.91	1.91	1.97	1.46	1.17
Total Debt to Equity (x)	0.32	0.33	0.32	0.43	0.56
Contingent Liabilities	18.76	18.75	9.39	16.56	12.77

All figures in Rs Cr, unless mentioned otherwise

View Details

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 22.09 cr is 0.51 times compared to the reported net profit of Rs 43.52 cr. (Source: Consolidated Financials)
Decrease in Cash from Investing
Company has used Rs 15.95 cr for investing activities which is an YoY decrease of 33.44%. (Source: Consolidated Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	22.09	16.09	34.39	56.98	0.33
Net Cash used in Investing Activities	-15.95	-23.96	-15.59	-15.65	-5.47
Net Cash flow from Financing Activities	-8.77	0.14	-17.55	-25.65	6.72
Net Cash Flow	-2.62	-7.73	1.26	15.68	1.59
Closing Cash & Cash Equivalent	9.92	12.55	20.28	19.02	3.34
Closing Cash & Cash Equivalent Growth (%)	-20.92	-38.13	6.63	469.15	90.43
Total Debt/ CFO (x)	4.34	5.71	2.28	1.39	269.55

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	22.04	16.07	34.39	56.98	0.33
Net Cash used in Investing Activities	-15.96	-23.96	-15.58	-15.65	-5.46
Net Cash flow from Financing Activities	-8.77	0.14	-17.55	-25.65	6.72
Net Cash Flow	-2.68	-7.75	1.26	15.68	1.60
Closing Cash & Cash Equivalent	9.83	12.51	20.27	19.00	3.33
Closing Cash & Cash Equivalent Growth (%)	-21.45	-38.26	6.64	471.04	92.53
Total Debt/ CFO (x)	4.35	5.72	2.28	1.39	266.39

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	11.52	16.76	25.35	16.33	13.54
Return on Capital Employed (%)	10.68	18.26	29.12	18.35	15.81
Return on Assets (%)	7.68	11.07	17.03	9.61	7.08
Interest Coverage Ratio (x)	6.00	8.26	11.64	3.51	2.40
Asset Turnover Ratio (x)	0.71	0.75	1.05	62.15	57.61
Price to Earnings (x)	46.51	18.87	11.79	7.22	8.90
Price to Book (x)	5.34	3.16	2.99	1.18	1.20
EV/EBITDA (x)	37.19	14.52	8.91	5.87	7.76
EBITDA Margin (%)	14.73	22.28	25.89	23.02	19.40

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	8.21	15.36	25.28	14.32	9.98
Return on Capital Employed (%)	13.12	21.58	33.80	21.39	18.01
Return on Assets (%)	5.05	9.48	16.04	7.86	4.87
Interest Coverage Ratio (x)	6.00	8.26	11.65	3.54	2.40
Asset Turnover Ratio (x)	0.81	0.84	1.09	68.16	61.80
Price to Earnings (x)	81.97	24.81	13.95	9.68	13.87
Price to Book (x)	6.69	3.81	3.53	1.39	1.38
EV/EBITDA (x)	37.17	14.52	8.91	5.83	7.76
EBITDA Margin (%)	14.74	22.28	25.89	23.19	19.42

Financial InsightsThemis Medicare

Income (P&L)
Cash Flow

- Employee & Interest Expense
  Company has spent 2.46% of its operating revenues towards interest expenses and 21.59% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
- Cash from Operations vs PAT
  Operating cash flow of Rs 22.09 cr is 0.51 times compared to the reported net profit of Rs 43.52 cr. (Source: Consolidated Financials)
- Decrease in Cash from Investing
  Company has used Rs 15.95 cr for investing activities which is an YoY decrease of 33.44%. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Themis Medicare Peer Comparison

Themis Medicare Stock Performance
Ratio Performance

CHART
TABLE

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 177.91% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 177.91% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Themis Medicare Stock Performance	-0.33	3.13	0.41	-11.66	43.94	176.99	723.23
Solara Active Pharma Stock Performance	1.99	40.86	18.87	37.24	65.41	-65.37	28.80
IOL Chemicals Stock Performance	5.29	19.79	15.78	9.38	-4.88	-34.17	99.70
Suven Life Sci Stock Performance	-1.53	16.06	7.85	1.20	78.37	10.06	-60.50
Amrutanjan Health Care Stock Performance	-0.16	13.54	7.13	17.97	33.15	12.15	140.61
Add More

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 177.91% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 177.91% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Themis Medicare	44.21	5.10	11.52	10.68	7.68	17.96	11.52	6.47	4.73	1.90	0.25	4.34
Solara Active Pharma	-5.00	3.03	-60.76	-17.42	-24.13	-7.62	-14.98	-43.98	-157.62	0.64	1.07	9.18
IOL Chemicals	18.76	1.56	8.34	11.74	5.98	2.77	9.27	6.30	22.90	2.00	0.02	0.11
Suven Life Sci	-22.26	8.66	-38.91	-41.77	-36.88	15.46	-969.62	-898.63	-4.82	18.99	0.00	0.00
Amrutanjan Health Care	50.52	7.87	15.58	20.91	12.25	8.30	14.74	10.67	15.56	4.23	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

SMS Pharma
Zota Healthcare
NGL Fine Chem
Lincoln Pharma
Syncom Form

Choose from Stocks

See All Parameters

Peers InsightsThemis Medicare

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 177.91% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 177.91% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Themis Medicare Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Themis Medicare Shareholding as on 31 Mar 2024
Category 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Promoters 67.15 67.16 67.16 67.16
Pledge 2.43 2.43 23.51 23.51
FII 0.03 0.01 0.05 0.04
DII 0.00 0.00 0.00 0.00
Mutual Funds 0.00 0.00 0.00 0.00
Others 32.81 32.83 32.79 32.80
Showing Shareholding as on 31 Mar 2024
Category No. of Shares Percentage % Change QoQ
Promoters 6,18,03,990 67.15 % 0.00
Pledge 15,00,000 2.43 % 0.00
FII 29,984 0.03 % 0.01
DII 394 0.00 % 0.00
MF 394 0.00 % 0.00
Others 3,02,05,752 32.81 % -0.01

Category	31 Mar 2024	31 Dec 2023	30 Sep 2023	30 Jun 2023
Promoters	67.15	67.16	67.16	67.16
Pledge	2.43	2.43	23.51	23.51
FII	0.03	0.01	0.05	0.04
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	32.81	32.83	32.79	32.80

Category	No. of Shares	Percentage	% Change QoQ
Promoters	6,18,03,990	67.15 %	0.00
Pledge	15,00,000	2.43 %	0.00
FII	29,984	0.03 %	0.01
DII	394	0.00 %	0.00
MF	394	0.00 %	0.00
Others	3,02,05,752	32.81 %	-0.01

MF Ownership

Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.01
  Amount Invested (in Cr.)
- 0.06%
  % of AUM
- 9.34
  % Change (MoM basis)

MF Ownership as on 31 May 2024

View all Mutual Fund Schemes

Corporate Actions

Themis Medicare Board Meeting/AGM
Themis Medicare Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 14, 2024	May 03, 2024	Board Meeting	Audited Results & Final Dividend
Feb 10, 2024	Jan 29, 2024	Board Meeting	Quarterly Results
Nov 17, 2023	Oct 16, 2023	POM	-
Nov 04, 2023	Oct 25, 2023	Board Meeting	Quarterly Results
Sep 09, 2023	Jul 22, 2023	AGM	Annual General Meeting/Dividend - Rs 5 Per Share

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	50%	5.0	Sep 01, 2023	May 15, 2023
Final	50%	5.0	Sep 08, 2022	May 23, 2022
Final	43%	4.3	Sep 08, 2021	May 27, 2021
Final	17%	1.75	Sep 17, 2020	Jun 08, 2020
Final	50%	0.5	-	May 14, 2024

All Types Ex-Date Record Date Announced on Details
Splits Oct 10, 2023 Oct 10, 2023 May 13, 2023 Split: Old FV10.0| New FV:1.0

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Oct 10, 2023	Oct 10, 2023	May 13, 2023	Split: Old FV10.0\| New FV:1.0

About Themis Medicare

Themis Medicare Ltd., incorporated in the year 1969, is a Small Cap company (having a market cap of Rs 1,930.82 Crore) operating in Pharmaceuticals sector. Themis Medicare Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024. Show More

Executives
Auditors

DS
Dinesh S Patel
Chairman & Executive Director
SD
Sachin D Patel
Managing Director & CEO
AD
Adam Demeter
Non Executive Director
RA
Rajneesh Anand
Non Executive Director
BV
Bhaskar V Iyer
Independent Director
HS
Hariharan Subramaniam
Independent Director
MS
Manjul Sandhu
Independent Director
SD
Shishir Dalal
Independent Director
RS
Reena S Patel
Alternate Director
TJ
Tushar J Dalal
Chief Financial Officer
SI
Sangameshwar Iyer
Co. Secretary & Compl. Officer
Show More
Krishaan & Co.
R P Sardar & Co.

Industry

Pharma - Indian

Key Indices Listed on

BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more

Address

Plot No.69-A,GIDC Industrial Estate,Vapi,Valsad District, Gujarat - 396195

Contact

[email protected]

http://www.themismedicare.com

More Details

FAQs about Themis Medicare share

1. What's Themis Medicare share price today and what are Themis Medicare share returns ?
Themis Medicare share price was Rs 209.10 as on 02 Jul, 2024, 02:48 PM IST. Themis Medicare share price was down by 0.33% based on previous share price of Rs 209.69. Themis Medicare share price trend:
- Last 1 Month: Themis Medicare share price moved up by 3.13%
- Last 3 Months: Themis Medicare share price moved down by 7.21%
- Last 12 Months: Themis Medicare share price moved up 53.80%
- Last 3 Years: Themis Medicare Share price moved up by 212.42%
2. Who's the chairman of Themis Medicare?
Dinesh S Patel is the Chairman & Executive Director of Themis Medicare
3. What dividend is Themis Medicare giving?
An equity Final dividend of Rs 5 per share was declared by Themis Medicare Ltd. on 15 May 2023. So, company has declared a dividend of 50% on face value of Rs 1 per share. The ex dividend date was 01 Sep 2023.
4. Which are the key peers to Themis Medicare?
Top 10 Peers for Themis Medicare are SMS Pharmaceuticals Ltd., Amrutanjan Health Care Ltd., Solara Active Pharma Sciences Ltd., Suven Life Sciences Ltd., IOL Chemicals and Pharmaceuticals Ltd., Zota Healthcare Ltd., NGL Fine - Chem Ltd., Lincoln Pharmaceuticals Ltd., Kopran Ltd. and Syncom Formulation (India) Ltd.
5. What's the market capitalization of Themis Medicare?
Market Capitalization of Themis Medicare stock is Rs 1,923.73 Cr.
6. What is the PE & PB ratio of Themis Medicare?
The PE ratio of Themis Medicare stands at 44.36, while the PB ratio is 5.11.
7. What are the key metrics to analyse Themis Medicare Share Price?
Key Metrics for Themis Medicare are:
- PE Ratio of Themis Medicare is 44.32
- Price/Sales ratio of Themis Medicare is 5.28
- Price to Book ratio of Themis Medicare is 5.11
8. What are the returns for Themis Medicare share?
Return Performance of Themis Medicare Shares:
- 1 Week: Themis Medicare share price moved down by 4.63%
- 1 Month: Themis Medicare share price moved up by 3.13%
- 3 Month: Themis Medicare share price moved down by 7.21%
- 6 Month: Themis Medicare share price moved down by 4.04%
9. What is the CAGR of Themis Medicare?
The CAGR of Themis Medicare is 13.42.
10. Who owns Themis Medicare?
Following are the key changes to Themis Medicare shareholding:
- Promoter holding have gone down from 67.16 (30 Jun 2023) to 67.15 (31 Mar 2024)
- Domestic Institutional Investors holding has not changed in last 9 months and holds 0.0 stake as on 31 Mar 2024
- Foreign Institutional Investors holding have gone down from 0.04 (30 Jun 2023) to 0.03 (31 Mar 2024)
- Other investor holding has gone up from 32.8 (30 Jun 2023) to 32.81 (31 Mar 2024)
11. What is 52 week high/low of Themis Medicare share price?
Themis Medicare share price saw a 52 week high of Rs 263.85 and 52 week low of Rs 132.60.
12. Who is the CEO of Themis Medicare?
Sachin D Patel is the Managing Director & CEO of Themis Medicare
13. What are the Themis Medicare quarterly results?
On Consoldiated basis, Themis Medicare reported a total income and profit of Rs 98.92 Cr and Rs 6.64 respectively for quarter ending 2024-03-31. Total Income and profit for the year ending 2024-03-31 was Rs 386.52 Cr and Rs 43.52 Cr.

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

1 Day	-0.54%
1 Week	-5.06%
1 Month	2.76%
3 Months	-7.52%
1 Year	53.22%
3 Years	211.37%
5 Years	890.26%

Themis Medicare Share Price

Themis Medicare Share P...

Themis Medicare share price insights

InsightsThemis Medicare

Key Metrics

Key Metrics

Themis Medicare Share Price Returns

ET Stock ScreenersTop Score Companies

Themis Medicare News & Analysis

Themis Medicare Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Themis Medicare Share Recommendations

Themis Medicare Financials

Income (P&L)

Balance Sheet

Cash Flow

Ratios

Insights

Insights

Financial InsightsThemis Medicare

Themis Medicare Peer Comparison

Themis Medicare Stock Performance

Ratio Performance

Insights

Insights

Ratio Performance

Peers InsightsThemis Medicare

Themis Medicare Shareholding Pattern

QOQ Change

Total Shareholdings

MF Ownership

Motilal Oswal BSE Healthcare ETF-G

Equity: Sectoral-Pharma

Top Searches:

Corporate Actions

Themis Medicare Board Meeting/AGM

Themis Medicare Dividends

About Themis Medicare

Executives

Auditors

More Details

FAQs about Themis Medicare share

Trending in Markets

Themis Medicare Quick Links

Equity Quick Links

More from Markets